Wednesday - September 23, 2026
FDA Center for Drug Evaluation & Research Issues Warning Letter to Empower Pharmacy
September 23, 2026
WASHINGTON, Sept. 23 -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following warning letter to Empower Clinic Services LLC dba Empower Pharmacy from its Center for Drug Evaluation and Research:

* * *

Recipient: Arta Shaun Noorian, Founder & Chief Executive Officer, Empower Clinic Services, LLC dba Empower Pharmacy, 7601 N. Sam Houston Pkwy W., Ste. 100, Houston, TX 77064-3595, United States

(b)(4)

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Click here for more information about our products